A human ESC line for efficient CRISPR editing of pluripotent stem cells
Human pluripotent stem cells (hPSC) can be directed to differentiate in vitro into insulin-prorducing beta cells (SC-β). Although these cells accurately respond to glucose and can reverse diabetes in preclinical models improvments in the final cell products are desirable. For example, safety, contro...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c13124af03dd436c9fac4750b2a61845 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|